Phosphorylation status of glucocorticoid receptor, heat shock protein 70, cytochrome c and Bax in lymphocytes of euthymic, depressed and manic bipolar patients

Psychoneuroendocrinology

Volumn 34, Issue 8, 2009, Pages 1162-1175

  Bei, E ^a   Salpeas, V ^a   Pappa, D ^b   Anagnostara, C ^b   Alevizos, V ^b   Moutsatsou, P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Apoptosis; Bax; Bipolar disorder; Cytochrome c; Heat shock protein 70; Serine 211 phosphorylation of hGR

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLOPENTHIXOL; CLOZAPINE; CYTOCHROME C; FLUOXETINE; GLUCOCORTICOID RECEPTOR; HALOPERIDOL; HEAT SHOCK PROTEIN 70; LAMOTRIGINE; LEVOMEPROMAZINE; LITHIUM CARBONATE; LITHIUM SULFATE; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; OXCARBAZEPINE; PERPHENAZINE; PROTEIN BAX; QUETIAPINE; RISPERIDONE; SERTRALINE; TRAZODONE; TRIFLUOPERAZINE; VALPROIC ACID; VENLAFAXINE;

ADULT; AGED; APOPTOSIS; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; BIPOLAR DISORDER; CYTOCHROMES C; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; HYDROCORTISONE; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; PHOSPHORYLATION; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, GLUCOCORTICOID;

EID: 67650739234     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.03.002     Document Type: Article

References (103)

1. Arya R., Mallik M., and Lakhotia S.C. Heat shock genes-integrating cell survival and death. J. Biosci. 32 (2007) 595-610
2. Bamberger C.M., Bamberger A.M., de Castro M., and Chrousos G.P. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95 (1995) 2435-2441
3. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., and Shanks N. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 28 (2003) 49-65
4. Bauer M., Grof P., Gyulai L., Rasgon N., Glenn T., and P. W.C. Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bipolar Disord. 6 (2004) 67-74
5. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
6. Beato M., and Sanchez-Pacheco A. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr. Rev. 17 (1996) 587-609
7. Benes F.M., Matzilevich D., Burke R.E., and Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 11 (2006) 241-251
8. Blanco J.C.G., Minucci S., Lu J., Yang X.J., Walker K.K., Chen H., et al. The histone acetylase PCAF is a nuclear receptor coactivator. Genes. Dev. 12 (1998) 1638-1651
9. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 97 (1968) 77-89
10. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
11. Calfa G., Kademian S., Ceschin D., Vega G., Rabinovich G.A., and Volosin M. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment. Psychoneuroendocrinology 28 (2003) 687-701
12. Chan J.Y., Cheng H.L., Chou J.L., Li F.C., Dai K.Y., Chan S.H., and Chang A.Y. Heat shock protein 60 or 70 activates nitric-oxide synthase (NOS) I- and inhibits NOS II-associated signaling and depresses the mitochondrial apoptotic cascade during brain stem death. J. Biol. Chem. 282 7 (2007) 4585-4600
13. Chen W., Dang T., Blind R.D., Wang Z., Cavasotto C.N., Hittelman A.B., Rogatsky I., Logan S.K., and Garabedian M.J. Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol. Endocrinol. 22 (2008) 1754-1766
14. Chrousos G.P., and Kino T. Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE 304 (2005) pe48
15. Chrousos G.P., and Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10 2 (2007) 213-219
16. Daban C., Vieta E., Mackin P., and Young A.H. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr. Clin. N. Am. 28 (2005) 469-480
17. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., and Lyoo I.K. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 61 (2004) 450-458
18. De Bosscher K., Van den Berghe W., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24 (2003) 488-522
19. De Bosscher K., Berghe W.V., Beck I.M.E., Molle W.V., Hennuyer N., Hapgood J., Libert C., Staels B., Louw A., and Haegeman G. A fully dissociated compound of plant origin for inflammatory gene repression. Proc. Natl. Acad. Sci. U.S.A. 102 44 (2005) 15827-15832
20. Deroo B.J., Rentsch C., Sampath S., Young J., DeFranco D.B., and Archer T.K. Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol. Cell. Biol. 22 12 (2002) 4113-4123
21. Dostert A., and Heinzel T. Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr. Pharm. Des. 10 23 (2004) 2807-2816
22. Duma D., Jewell C.M., and Cidlowski J.A. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102 (2006) 11-21
23. Dwivedi Y., Rao J.S., Rizavi H.S., Kotowski J., Conley R.R., Roberts R.C., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch. Gen. Psychiatry 60 (2003) 273-282
24. Eilat E., Mendlovic S., Doron A., Zakuth V., and Spirer Z. Increased apoptosis in patients with major depression: a preliminary study. J. Immunol. 163 (1999) 533-534
25. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr. Res. 72 (2005) 109-122
26. First M.B., Spitzer R.L., and Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders (1997), Research Version Biometrics Research, New York
27. Garrido C., Gurbuxani S., Ravagnan L., and Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem. Biophys. Res. Commun. 286 (2001) 433-442
28. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., and Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 13 (2006) 1423-1433
29. Gould T.D., and Manji H.K. Signaling networks in the pathophysiology and treatment of mood disorders. J. Psychosom. Res. 53 (2002) 687-697
30. Guo F., Sigua C., Bali P., George P., Fiskus W., Scuto A., Annavarapu S., Mouttaki A., Sondarva G., Wei S., Wu J., Djeu J., and Bhalla K. Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells. Blood 105 3 (2005) 1246-1255
31. Hahn C.G., Gomez G., Restrepo D., Friedman E., Josiassen R., Pribitkin E.A., Lowry L.D., Gallop R.J., and Rawson N.E. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am. J. Psychiatry 162 (2005) 616-618
32. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
33. Hennen J. Statistical methods for longitudinal research on bipolar disorders. Bipolar Disord. 5 (2003) 156-168
34. Hollenberg S.M., Weinberger C., Ong E.S., Cerelli G., Oro A., Lebo R., et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318 6047 (1985) 635-641
35. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., and Adcock I.M. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109 (2002) 649-657
36. Ismaili N., and Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 1024 (2004) 86-101
37. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., and Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol. Endocrinol. 16 (2002) 2382-2392
38. Ivanova S.A., Semke V.Ya., Vetlugina T.P., Rakitina N.M., Kudyakova T.A., and Simutkin G.G. Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci. Behav. Physiol. 37 5 (2007) 527-530
39. Jarskog L.F., Gilmore J.H., Glantz L.A., Gable K.L., German T.T., Tong R.I., et al. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology 32 1 (2007) 95-102
40. Jensen J.B., Shimon H., and Mõrk A. Abnormal protein phosphorylation in post-mortem brain tissue from bipolar patients. J. Neural. Transm. 107 (2000) 501-509
41. Jones T.J., Li D., Wolf I.M., Wadekar S.A., Periyasamy S., and Sánchez E.R. Enhancement of glucocorticoid receptor-mediated gene expression by constitutively active heat shock factor 1. Mol. Endocrinol. 18 3 (2004) 509-520
42. Juruena M.F., Cleare A.J., Bauer M.E., and Pariante C.M. Molecular mechanisms of glucocorticoid receptor sensitivity and relevance to affective disorders. Acta Neuropsychiatrica 15 (2003) 354-367
43. Kato T., and Takahashi Y. Deletion of leukocyte mitochondrial DNA in bipolar disorder. J. Affect. Disord. 37 (1996) 67-73
44. Kato T., Stine O.C., McMahon F.J., and Crowe R.R. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol. Psychiatry 42 (1997) 871-875
45. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2 3 Part 1 (2000) 180-190
46. Kazuno A.A., Munakata K., Nagai T., Shimozono S., Tanaka M., Yoneda M., et al. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS. Genet. 2 8 (2006) e128
47. Kino T., De Martino M.U., Charmandari E., Mirani M., and Chrousos G.P. Tissue glucocorticoid resistance/hypersensitivity syndromes. J. Steroid Biochem. Mol. Biol. 85 (2003) 457-467
48. Kino T., Tiulpakov A., Ichijo T., Chheng L., Kozasa T., and Chrousos G.P. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J. Cell. Biol. 169 (2005) 885-896
49. Kino T., Ichijo T., Amin N.D., Kesavapany S., Wang Y., Kim N., et al. Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol. Endocrinol. 21 7 (2007) 1552-1568
50. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61 (2004) 300-308
51. Koubovec D., Ronacher K., Stubsrud E., Louw A., and Hapgood J.P. Synthetic progestins used in HRT have different glucocorticoid agonist properties. Mol. Cell. Endocrinol. 242 (2005) 23-32
52. Lämmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
53. Lee M.J., Wang Z., Yee H., Ma Y., Swenson N., Yang L., et al. Expression and regulation of glucocorticoid receptor in human placental villous fibroblasts. Endocrinology 146 11 (2005) 4619-4626
54. Li C.Y., Lee J.S., Ko Y.G., Kim J., and Seo J.S. Hsp70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J. Biol. Chem. 275 (2000) 25665-25671
55. Li X., Friedman A.B., Zhu W., Wang L., Boswell S., May R.S., et al. Lithium regulates glycogen synthase kinase-3β in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder. Biol. Psychiatry 61 (2007) 216-222
56. Lowy M.T. Reserpine-induced decrease in type I and II corticosteroid receptors in neuronal and lymphoid tissues of adrenalectomized rats. Neuroendocrinology 51 (1990) 190-196
57. Lu N.Z., and Cidlowski J.A. Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Mol. Cell. 18 3 (2005) 331-342
58. Manier D.H., Eiring A., Shelton R.C., and Sulser F. Beta-adrenoceptor-linked protein kinase A (PKA) activity in human fibroblasts from normal subjects and from patients with major depression. Neuropsychopharmacology 15 (1996) 555-561
59. Manoli I., Alesci S., Blackman M.R., Su Y.A., Rennert O.M., and Chrousos G.P. Mitochondria as key components of the stress response. Trends Endocrinol. Metab. 18 5 (2007) 190-198
60. Matsubara T., Funato H., Kobayashi A., Nobumoto M., and Watanabe Y. Reduced glucocorticoid receptor α expression in mood disorder patients and first-degree relatives. Biol. Psychiatry 59 (2006) 689-695
61. McCurdy R.D., Fιron F., Perry C., Chant D.C., McLean D., Matigian N., et al. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr. Res. 82 (2006) 163-173
62. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
63. Miller A.L., Webb M.S., Copik A.J., Wang Y., Johnson B.H., Kumar R., et al. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol. 19 (2005) 1569-1583
64. Miller A.L., Garza A.S., Johnson B.H., and Thompson E.B. Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int. 7 (2007) 3
65. Moretti A., Gorini A., and Villa R.F. Affective disorders, antidepressant drugs and brain metabolism. Mol. Psychiatry 8 (2003) 773-785
66. Moutsatsou P., Tsolakidou A., Trikkas G., Troungos C., and Sekeris C.E. Glucocorticoid receptor alpha and beta isoforms are not mutated in bipolar affective disorder. Mol. Psychiatry 5 2 (2000) 196-202
67. Munakata K., Tanaka M., Mori K., Washizuka S., Yoneda M., Tajima O., et al. Mitochondrial DNA 3644T→C mutation associated with bipolar disorder. Genomics 84 6 (2004) 1041-1050
68. Munakata K., Iwamoto K., Bundo M., and Kato T. Mitochondrial DNA 3243A > G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57 5 (2005) 525-532
69. Munakata K., Fujii K., Nanko S., Kunugi H., and Kato T. Sequence and functional analyses of mtDNA in a maternally inherited family with bipolar disorder and depression. Mutat. Res. 617 1-2 (2007) 119-124
70. Ng W.X., Lau I.Y., Graham S., and Sim K. Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis. Neurosci. Biobehav. Rev. 33 3 (2009) 336-354
71. Olley A., Malhi G.S., Mitchell P.B., Batchelor J., Lagopoulos J., and Austin M.-P.V. When euthymia is just not good enough. The neuropsychology of bipolar disorder. J. Nerv. Ment. Dis. 193 (2005) 323-330
72. Parcellier A., Gurbuxani S., Schmitt E., Solary E., and Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochem. Biophys. Res. Commun. 304 (2003) 505-512
73. Pariante C.M. Glucocorticoid receptor function in vitro in patients with major depression. Stress 7 4 (2004) 209-219
74. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., and Zanardi R. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch. Gen. Psychiatry 56 3 (1999) 248-253
75. Perlman W.R., Webster M.J., Kleinman J.E., and Weickert C.S. Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness. Biol. Psychiatry 56 (2004) 844-852
76. Pratt W.B., Morishima Y., Murphy M., and Harrell M. Chaperoning of glucocorticoid receptors. Handb. Exp. Pharmacol. 172 (2006) 111-138
77. Raison C.L., and Miller A.H. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160 (2003) 1554-1565
78. Schreiber E., Matthias P., Móller M.M., and Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 15
79. Shelton R.C., Mainer D.H., and Sulser F. cAMP-dependent protein kinase activity in major depression. Am. J. Psychiatry 153 8 (1996) 1037-1042
80. Shimizu S., Nomura K., Ujihara M., Sakamoto K., Shibata H., Suzuki T., and Demura H. An allel-specific abnormal transcript of the heat shock protein 70 gene in patients with major depression. Biochem. Biophys. Res. Commun. 219 3 (1996) 745-752
81. Shimizu E., Kodama K., Sakamoto T., Komatsu N., Yamanouchi N., Okada S., et al. Recovery from neuroendocrinological abnormalities and frontal hypoperfusion after remission in a case with rapid-cycling bipolar disorder. Psychiatry Clin. Neurosci. 51 (1997) 207-212
82. Spencer R.L., Miller A.H., Stein M., and McEwen B.S. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. Brain. Res. 549 (1991) 236-246
83. Spiliotaki M., Salpeas V., Malitas P., Alevizos V., and Moutsatsou P. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients. Psychoneuroendocrinology 31 6 (2006) 748-760
84. Stankiewicz A.R., Lachapelle G., Foo C.P., Radicioni S.M., and Mosser D.D. Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J. Biol. Chem. 280 (2005) 38729-38739
85. Stork C., and Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10 (2005) 900-919
86. Sulser F. The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression. Ann. Med. 34 (2002) 348-356
87. Sun X., Wang J.-F., Tseng M., and Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J. Psychiatry Neurosci. 31 3 (2006) 189-196
88. Syvälahti E., Eskola J., Ruuskanen O., and Laine T. Nonsuppression of cortisol in depression and immune function. Prog. Neuropsychopharmacol. Biol. Psychiatry 9 4 (1985) 413-422
89. Szuster-Ciesielska A., Słotwińska M., Stachura A., Marmurowska-Michałowska H., Dubas-Slemp H., Bojarska-Junak A., and Kandefer-Szerszeń M. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 3 (2008) 686-694
90. Takimoto T., Nakamura K., Ueno H., Matsuda M., Fukunishi I., Ameno K., and Iwahashi K. Major depression and heat shock protein 70-1 gene. Clin. Chim. Acta. 332 1-2 (2003) 133-137
91. Wang Z., Frederick J., and Garabedian M.J. Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo. J. Biol. Chem. 277 (2002) 26573-26580
92. Wang Z., Chen W., Kono E., Dang T., and Garabedian M.J. Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase. Mol. Endocrinol. 21 3 (2007) 625-634
93. Washizuka S., Kakiuchi C., Mori K., Tajima O., Akiyama T., and Kato T. Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord. 7 2 (2005) 146-152
94. Watson S., Gallagher P., Ritchie J.C., Ferrier N., and Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 184 (2004) 496-502
95. Watson S., Thompson J.M., Malik N., Ferrier I.N., and Young A.H. Temporal stability of the dex/CRH test in patients with rapid-cycling bipolar I disorder: a pilot study. Aust. N. Z. J. Psychiatry 39 (2005) 244-248
96. Watson S., Thompson J.M., Ritchie J.C., Ferrier I.N., and Young A.H. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function. Bipolar Disord. 8 1 (2006) 85-90
97. Webster M.J., Knable M.B., Johnston-Wilson N., Nagata K., Inagaki M., and Yolken R.H. Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain. Behav. Immun. 15 (2001) 388-400
98. Webster M.J., Knable M.B., O'Grady J., Orthmann J., and Weickert C.S. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol. Psychiatry 7 9 (2002) 985-994
99. Wothke W. Longitudinal and multi-group modeling with missing data. In: Little T.D., Schnabel K.U., and Baumert J. (Eds). Modeling Longitudinal and Multiple Group Data: Practical Issues, Applied Approaches and Specific Examples. (2000), Lawrence Erlbaum Associates, Mahwah, NJ 1-24
100. Xing G., Zhang L., Russell S., and Post R. Reduction of dopamine-related transcription factors Nurr1 and NGFI-B in the prefrontal cortex in schizophrenia and bipolar disorders. Schizophr. Res. 84 (2006) 36-56
101. Yehuda R., Boisoneau D., Mason J.W., and Giller E.L. Glucocorticoid receptor number and cortisol excretion in mood, anxiety and psychotic disorders. Biol. Psychiatry 34 1-2 (1993) 18-25
102. Yenari M.A., Liu J., Zheng Z., Vexler Z.S., Lee J.E., and Giffard R.G. Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection. Ann. N. Y. Acad. Sci. 1053 (2005) 74-83
103. Young R.C., Briggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133 (1978) 429-435